SUPERGEN INC SUPG (NASDAQ)

$ 1.60
19:09
Change: -0.01 (-0.62%)
Volume: 71,900

Avg. Volume: 120650
P/E Ratio: 0
EPS (Annual): -0.01
Profit Margin:
Dividend & Yield(Annual): 0%
Shares Outstanding: 57,520
Institutional Shareholders: 48.12%
Last: 1.60
Change: -0.01 (-0.62%)
Prev. Close: 1.61
Open: 1.61
Day's Range: 1.59 - 1.62
52wk Range: 1.48 - 4.89
Market Value: 92,680
Beta: 2.74
12-month EPS Change: 0.00%
Total Return Last 12 Months: -61.63%
Total Return Last 3 Years: -123.50%
Total Return Last 5 Years: -75.23%
5-Year Revenue Growth Rate: 0.00%
5-Year Dividend Growth Rate: 0.00%
5-Year EPS Growth Rate: 0.00%


Headlines on SUPG
Alert me Subscribe

SuperGen drug candidate gets special designation

(DUBLIN, Calif.)SuperGen Inc. said Thursday the Food and Drug Administration granted its developing brain-cancer treatment special status, giving it financial and market incentives.READ MORE
Aug 07, 2008 9:24AM
Keywords: SUPG

Celgene shares rise as rival's drug fails study

(NEW YORK)Shares of biotechnology company Celgene Corp. advanced Tuesday as a potential competitor to its bone-marrow cancer treatment in Europe failed a late-stage clinical trial.READ MORE
Jul 01, 2008 6:43PM
Keywords: CELG, SUPG

Nasdaq 100 Leaders and Laggards: CELG UAUA

(NEW YORK)The Nasdaq 100 index rose Tuesday as shares of biopharmaceutical company Celgene Corp. advanced after competitor SuperGen Inc.'s bone marrow cancer drug Dacogen failed a late-s...READ MORE
Jul 01, 2008 4:45PM
Keywords: CELG, SUPG, PETM, BIIB, UAUA, SNDK, MNST, DB

Outlook roundup: Wonder Auto, SuperGen

Among the earnings projection stories for Tuesday, July 1, from AP Financial News: NEW YORK (AP)--Chinese automotive supplier Wonder Auto Technology Inc. said Tuesday it expects it...READ MORE
Jul 01, 2008 2:05PM
Keywords: WATG, SUPG

Midday Leaders & Laggards: S&P 500

(NEW YORK)The Standard & Poor's 500 declined in midday trading on Tuesday, with the biggest fall taken by shares of Fortune Brands Inc., after the company lowered its outlook.READ MORE
Jul 01, 2008 12:24PM
Keywords: FO, S, MBI, CIT, STZ, CELG, SUPG

Out of the Gate: SuperGen drug trial fails

(NEW YORK)SuperGen Inc. said Tuesday its bone marrow disorder drug Dacogen failed in a late-stage European clinical trial, which pressured SuperGen shares and boosted Celgene Corp., which ma...READ MORE
Jul 01, 2008 10:46AM
Keywords: SUPG, CELG, JNJ

SuperGen reaffirms 2008 outlook following study

(DUBLIN, Calif.)Pharmaceutical company SuperGen Inc. on Tuesday reaffirmed its 2008 financial outlook after reporting a failed late-stage clinical trial for its drug candidate Dacogen.READ MORE
Jul 01, 2008 10:16AM
Keywords: SUPG
RSS Page | Sign up for Google Alerts


Data Provided By Barchart.com
advertisement

Top Competitors

PFIZER INC -19.50 18.51
MERCK CO INC -32.20 34.30
JOHNSON AND JOH +18.40 70.67
SCHERING PLOUGH -28.80 19.26
BRISTOL MYERS S -18.00 21.49